文献速递妇产影像泌尿生殖US

微囊型与声影是超声预测卵巢交界性肿瘤和囊腺纤维瘤的独立预测因子

Microcystic pattern and shadowing are independent predictors of ovarian borderline tumors and cystadenofibromas in ultrasound.
PubMed 文献 · Eur Radiol · 2020-08-11

回顾性分析650例附件原发上皮性肿瘤的术前超声,按国际卵巢肿瘤分析术语描述。囊腺纤维瘤中59.1%见声影,交界性肿瘤中53.1%见微囊型,两者分别为囊腺纤维瘤和交界性肿瘤的独立预测因子。

要点

  • 声影在囊腺纤维瘤中占59.1%,在囊腺瘤、交界性肿瘤、囊腺癌中分别仅占1.6%、5.5%、3.7%。
  • 微囊型在交界性肿瘤中占53.1%,在囊腺瘤、囊腺癌、囊腺纤维瘤中分别占2.0%、11.7%、18.2%。
  • 声影是囊腺纤维瘤的独立预测因子,微囊型是交界性肿瘤的独立预测因子。

核心结论

  • 囊腺纤维瘤和交界性肿瘤的超声表现复杂,且部分与囊腺癌重叠。
  • 正确识别和运用声影或微囊型可能有助于正确鉴别囊腺纤维瘤和交界性肿瘤。

研究设计与样本

  • 回顾性收集连续患者的术前超声图像,纳入至少有一个附件原发上皮性肿瘤者。
  • 共纳入650例患者:囊腺纤维瘤110例、交界性肿瘤128例、囊腺瘤249例、囊腺癌163例。
  • 所有肿瘤按国际卵巢肿瘤分析术语描述,超声变量经单因素分析后行多项逻辑回归检验。

关键影像表现/征象

  • 近半数囊腺纤维瘤及超过半数交界性肿瘤和囊腺癌在超声图像上表现为单房和多房实性,而囊腺瘤以单房或多房为主(p < 0.001)。
  • 总体650例中82例可见声影,囊腺纤维瘤110例中65例(59.1%)见声影,囊腺瘤249例中4例(1.6%)、交界性肿瘤128例中7例(5.5%)、囊腺癌163例中6例(3.7%)见声影(p < 0.001)。
  • 650例中112例显示微囊型,交界性肿瘤128例中68例(53.1%)见微囊型,囊腺瘤249例中5例(2.0%)、囊腺癌163例中19例(11.7%)、囊腺纤维瘤110例中20例(18.2%)见微囊型(p < 0.001)。

诊断标准与关键数值

  • 声影是囊腺纤维瘤的独立预测因子,微囊型是交界性肿瘤的独立预测因子。
  • 声影出现率:囊腺纤维瘤59.1%(65/110)vs 囊腺瘤1.6%(4/249)、交界性肿瘤5.5%(7/128)、囊腺癌3.7%(6/163),p < 0.001。
  • 微囊型出现率:交界性肿瘤53.1%(68/128)vs 囊腺瘤2.0%(5/249)、囊腺癌11.7%(19/163)、囊腺纤维瘤18.2%(20/110),p < 0.001。

临床应用与阅片要点

  • 阅片时注意识别声影,其更常见于囊腺纤维瘤而非囊腺瘤、交界性肿瘤或囊腺癌。
  • 阅片时注意识别微囊型,其更常见于交界性肿瘤而非囊腺瘤、囊腺癌或囊腺纤维瘤。
  • 囊腺纤维瘤和交界性肿瘤的超声表现可与囊腺癌重叠,需结合声影或微囊型等特征进行鉴别。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine the sonographic characteristics of borderline tumors (BoTs) and cystadenofibromas (CAFs).

METHODS: Preoperative sonograms from consecutive patients who had at least one primary epithelial tumor in the adnexa were retrospectively collected. All tumors were described using the International Ovarian Tumor Analysis terminology. Ultrasound variables were tested using multinomial logistic regression after univariate analysis.

RESULTS: A total of 650 patients were included in this study. Of these, 110 had a CAF, 128 had a BoT, 249 had a cystadenoma (CAD), and 163 had a cystadenocarcinoma (CAC). Nearly half of CAFs and more than half of BoTs and CACs appeared to be unilocular and multilocular solid on the ultrasound images, while CADs were predominantly uni- or multilocular (p < 0.001). Overall, shadowing was identified in 82/650 cases. Sixty-five of 110 (59.1%) CAFs exhibited an acoustic shadow, compared with only 4/249 (1.6%) in CADs, 7/128 (5.5%) in BoTs, and 6/163 (3.7%) in CACs (p < 0.001). Furthermore, 112/650 cases demonstrated microcystic pattern (MCP). Sixty-eight of 128 (53.1%) BoTs exhibited MCP, compared with only 5/249 (2.0%) in CADs, 19/163 (11.7%) in CACs, and 20/110 (18.2%) in CAFs (p < 0.001). Logistic regression analysis revealed that shadowing is an independent predictor of CAFs, while MCP is an independent predictor of BoTs.

CONCLUSIONS: Sonographic findings for CAFs and BoTs were complex and partly overlapped with those for CACs. However, proper recognition and utilization of shadowing or MCP may help to correctly discriminate CAFs and BoTs.

KEY POINTS: • Sonographic findings for borderline tumors and cystadenofibromas are complex and mimic malignancy. • Microcystic pattern and shadowing are independent predictors of borderline tumors and cystadenofibromas respectively.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zheng X, Lyu G, Gan Y, et al. Microcystic pattern and shadowing are independent predictors of ovarian borderline tumors and cystadenofibromas in ultrasound. Eur Radiol. 2020. PMID: 32780208. doi:10.1007/s00330-020-07113-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。